DOCMF (Dr. Martens) Cash Flow from Operations: $190 Mil (TTM As of Mar. 2026)


DOCMF Dr. Martens PLC DOCMF
55 GF Score
Price $0.97
GF Value $0.98
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Dr. Martens Cash Flow from Operations?

Dr. Martens DOCMF 55 Cash Flow from Operations is $190 Mil as of Mar. 2026. GuruFocus rates DOCMF with a GF Score™ of 55/100 and a GF Value™ of $0.98 (Fairly Valued). The stock has 3 warning signs investors should review.

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the six months ended in Mar. 2026, Dr. Martens's Net Income From Continuing Operations was $45 Mil. Its Depreciation, Depletion and Amortization was $43 Mil. Its Change In Working Capital was $83 Mil. Its cash flow from deferred tax was $13 Mil. Its Cash from Discontinued Operating Activities was $0 Mil. Its Asset Impairment Charge was $0 Mil. Its Stock Based Compensation was $2 Mil. And its Cash Flow from Others was $13 Mil. In all, Dr. Martens's Cash Flow from Operations for the six months ended in Mar. 2026 was $200 Mil.


Dr. Martens  (OTCPK:DOCMF) Cash Flow from Operations Explanation

For companies reported in indirect method, cash flow from operations contains six items:

1. Net Income From Continuing Operations:
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Dr. Martens's net income from continuing operations for the six months ended in Mar. 2026 was $45 Mil.

2. Depreciation, Depletion and Amortization:
Depreciation is a present expense that accounts for the past cost of an asset that is now providing benefits.
Depletion and amortization are synonyms for depreciation.
Generally:
The term depreciation is used when discussing man made tangible assets
The term depletion is used when discussing natural tangible assets
The term amortization is used when discussing intangible assets

Dr. Martens's depreciation, depletion and amortization for the six months ended in Mar. 2026 was $43 Mil.

3. Change In Working Capital:
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities. Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow.

Dr. Martens's change in working capital for the six months ended in Mar. 2026 was $83 Mil. It means Dr. Martens's working capital increased by $83 Mil from Sep. 2025 to Mar. 2026 .

4. Deferred Tax:
It is the cash flow generated from deferred tax.

Dr. Martens's cash flow from deferred tax for the six months ended in Mar. 2026 was $13 Mil.

5. Cash from Discontinued Operating Activities:
Net cash from all of the entity's discontinued operating activities.

Dr. Martens's cash from discontinued operating Activities for the six months ended in Mar. 2026 was $0 Mil.

6. Asset Impairment Charge:
It is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Dr. Martens's asset impairment charge for the six months ended in Mar. 2026 was $0 Mil.

7. Stock Based Compensation:
It is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Dr. Martens's stock based compensation for the six months ended in Mar. 2026 was $2 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).

Dr. Martens's cash flow from others for the six months ended in Mar. 2026 was $13 Mil.


Dr. Martens Cash Flow from Operations Related Terms


Dr. Martens Cash Flow from Operations Historical Data

* Premium members only.

The historical data trend for Dr. Martens's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr. Martens Cash Flow from Operations Chart

Dr. Martens Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cash Flow from Operations
Get a 7-Day Free Trial Premium Member Only 242.95 88.23 213.34 253.62 190.27

Dr. Martens Semi-Annual Data
Mar18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Cash Flow from Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 243.20 46.69 208.01 -9.73 199.87
DOCMF
55GF Score
Dr. Martens PLC DOCMF
Cash Flow from Operations is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr. Martens Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Dr. Martens's Cash Flow from Operations for the fiscal year that ended in Mar. 2026 is calculated as:

Dr. Martens's Cash Flow from Operations for the quarter that ended in Mar. 2026 is:


Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $190 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow from Operations of $190 Mil mean?
Dr. Martens (DOCMF) has a Cash Flow from Operations of $190 Mil as of Mar. 2026. Cash Flow from Operations is the amount of cash earned or paid from standard business operations. View historical data for Dr. Martens and its competitors.
Is Dr. Martens' Cash Flow from Operations too high?
Dr. Martens' current Cash Flow from Operations is $190 Mil. Overall, Dr. Martens has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr. Martens' Cash Flow from Operations compare to NKE and DECK?
Dr. Martens' Cash Flow from Operations of $190 Mil can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Operations for a Manufacturing - Apparel & Accessories company?
A good Cash Flow from Operations depends on the Manufacturing - Apparel & Accessories industry context. However, Cash Flow from Operations should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Operations mean?
A high Cash Flow from Operations can signal that a stock is expensive relative to its fundamentals. Cash Flow from Operations is the amount of cash earned or paid from standard business operations. View historical data for Dr. Martens and its competitors. Dr. Martens's current Cash Flow from Operations is $190 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Martens stock overvalued right now?
Based on GuruFocus' analysis, Dr. Martens (DOCMF) is currently considered Fairly Valued. The stock's GF Value™ is $0.98, compared to a current price of $0.97 — trading 1% below its estimated fair value. The current Cash Flow from Operations is $190 Mil. Dr. Martens' overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Operations calculated?
Cash Flow from Operations is calculated from a company's financial statements. For Dr. Martens (DOCMF), the current Cash Flow from Operations is $190 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr. Martens (DOCMF) Overvalued in 2026?

Based on GuruFocus' analysis, Dr. Martens stock appears to be undervalued. The current stock price of $0.97 is trading 1% below its estimated GF Value™ of $0.98. GuruFocus considers Dr. Martens to be Fairly Valued.

Key valuation signals for DOCMF:

  • Cash Flow from Operations: $190 Mil
  • GF Value™: $0.98 vs. price of $0.97 (1% below fair value)
  • GF Score™: 55/100 with 3 warning signs

No single metric tells the full story. See the DOCMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dr. Martens Business Description

Address 28 Jamestown Road, Camden, London, GBR, NW1 7BY
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
55GF Score

Get the complete analysis for DOCMF

Cash Flow from Operations is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.97
Price
$0.98
GF Value